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Abstract
Background: Taenia solium and Taenia saginata are zoonotic parasites of public health importance. Data on their
occurrence in humans and animals in western Europe are incomplete and fragmented. In this study, we aimed to
update the current knowledge on the epidemiology of these parasites in this region.
Methods: We conducted a systematic review of scientific and grey literature published from 1990 to 2015 on the
epidemiology of T. saginata and T. solium in humans and animals. Additionally, data about disease occurrence were
actively sought by contacting local experts in the different countries.
Results: Taeniosis cases were found in twelve out of eighteen countries in western Europe. No cases were identified in
Iceland, Ireland, Luxembourg, Norway, Sweden and Switzerland. For Denmark, Netherlands, Portugal, Slovenia, Spain
and the UK, annual taeniosis cases were reported and the number of detected cases per year ranged between 1 and
114. Detected prevalences ranged from 0.05 to 0.27%, whereas estimated prevalences ranged from 0.02 to 0.67%. Most
taeniosis cases were reported as Taenia spp. or T. saginata, although T. solium was reported in Denmark, France, Italy,
Spain, Slovenia, Portugal and the UK. Human cysticercosis cases were reported in all western European countries
except for Iceland, with the highest number originating from Portugal and Spain. Most human cysticercosis cases were
suspected to have acquired the infection outside western Europe. Cases of T. solium in pigs were found in Austria and
Portugal, but only the two cases from Portugal were confirmed with molecular methods. Germany, Spain and Slovenia
reported porcine cysticercosis, but made no Taenia species distinction. Bovine cysticercosis was detected in all
countries except for Iceland, with a prevalence based on meat inspection of 0.0002–7.82%.
Conclusions: Detection and reporting of taeniosis in western Europe should be improved. The existence of T. solium
tapeworm carriers, of suspected autochthonous cases of human cysticercosis and the lack of confirmation of porcine
cysticercosis cases deserve further attention. Suspected cases of T. solium in pigs should be confirmed by molecular
methods. Both taeniosis and human cysticercosis should be notifiable and surveillance in animals should be improved.
Keywords: Taenia solium, Taenia saginata, Taeniasis, Neurocysticercosis, Porcine cysticercosis, Bovine cysticercosis
* Correspondence: minervalaranjo@gmail.com
1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la
Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Laranjo-González et al. Parasites & Vectors  (2017) 10:349 
DOI 10.1186/s13071-017-2280-8
Background
Taenia solium and Taenia saginata are zoonotic tape-
worm species that cause taeniosis in humans (definitive
host) and cysticercosis in pigs and cattle (intermediate
hosts), respectively. Humans can also acquire cysticerco-
sis after accidentally ingesting T. solium eggs. Cysticerci
in humans often establish in the central nervous system
causing neurocysticercosis (NCC) [1].
Human taeniosis causes few or no symptoms [2] al-
though it can cause psychological stress [3]. Animal
cysticercosis is normally asymptomatic, particularly if
infections are light. However, cases are responsible for
substantial economic losses to the meat sector [4]. NCC
may be asymptomatic, but it can cause neurological
manifestations such as seizures, headaches, focal neuro-
logical deficits, signs of increased intracranial pressure
and deaths [5, 6] and is a leading cause of acquired
epilepsy in endemic areas [7].
Taenia solium is considered to be endemic in parts of
Asia, sub-Saharan Africa and South and Central America
[8]. In Europe, industrialisation of pig rearing systems and
improved sanitation are believed to have eliminated the
parasite [9, 10]. However, gaps regarding the true endem-
icity status of T. solium in Europe still remain [10].
According to a map on T. solium endemicity, recently
updated by the World Health Organization [8], some
countries in western Europe still have some pig herds at
risk of T. solium transmission. Furthermore, the epidemio-
logical situation in eastern Europe is unclear since there
are countries classified as endemic, with some pig herds at
risk, and countries from which data are lacking [8]. In
addition, T. solium in humans has been emerging as a
public health concern in Europe due to the increased
number of diagnosed NCC cases in recent decades. These
have been linked to increased travels and migratory move-
ments towards and from endemic countries [11–14].
Taenia saginata is distributed worldwide [15], and has
been found in cattle in countries of western and eastern
Europe. However, the available data are limited and
often of low quality [16]. Data on taeniosis due to T.
saginata are scarce, and among the data that do exist, its
prevalence is sometimes estimated from the sales of
anthelmintic drugs [17].
Taeniosis and human cysticercosis are not notifiable in
Europe as stated by Gäbriel et al. [9] and therefore it is
difficult to assess the epidemiology of these zoonoses in
the region. Detection and reporting of animal cysticercosis
cases is mainly based on official meat inspection. Porcine
cysticercosis has to be notified to the World Organisation
for Animal Health (OIE), but there is no mandatory
reporting for bovine cysticercosis. Despite the European
Directive 2003/99/EC [18] that recommends monitoring
animal cysticercosis according to the epidemiological
situation, few countries report these cases [16, 19].
Based on the need for useful estimates for taeniosis/
cysticercosis surveillance and control activities, as well
as to advance the knowledge and awareness of these
zoonotic disease complexes, the aim of this review was
to update and compile the current knowledge on the
epidemiology of T. solium and T. saginata in western
Europe (both in humans and animals). This review is
one of two systematic reviews: the present review covers
western Europe and a second review will cover eastern
Europe.
Methods
Study design
We conducted a systematic review supplemented by a
search of local and unpublished sources for information
on the occurrence, prevalence, incidence and the geo-
graphical distribution of human and animal T. saginata
and T. solium infections in western Europe published
from 1990 to 2015. This area was defined, based on
gross domestic product/gross national income (GDP/
GNI) and regional proximity, as including the following
countries: Austria, Belgium, Denmark, Finland, France,
Germany, Iceland, Ireland, Italy, Luxembourg, Norway,
the Netherlands, Portugal, Slovenia, Spain, Sweden,
Switzerland and the United Kingdom; and excluding
overseas territories and mini-states (e.g. Liechtenstein).
International databases
We searched the following online international data-
bases: PubMed, ISI Web of Knowledge, CABDirect,
OAIster and OpenGrey for all published data on the
topic and followed the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) guide-
lines for reporting systematic reviews (Additional file 1:
Table S1). The following search phrase was used: (cysti-
cerc* OR cisticerc* OR neurocysticerc* OR neurocisti-
cerc* OR “C. bovis” OR “C. cellulosae” OR taenia* OR
tenia* OR saginata OR solium OR taeniosis OR teniosis
OR ténia OR taeniid OR cysticerque) AND (Austria OR
België OR Belgiën OR Belgique OR Belgium OR
Denmark OR Deutschland OR Éire OR England OR
España OR Finland OR France OR Germany OR Iceland
OR Ireland OR Ísland OR Italia OR Italy OR
Luxembourg OR Nederland OR Netherlands OR
Norway OR Österreich OR Portugal OR Schweiz OR
Scotland OR Slovenia OR Slovenija OR Spain OR Suisse
OR Svizzera OR Sweden OR Switzerland OR United
Kingdom OR Wales). The databases were searched for
papers published from 1st January 1990 up to 1st De-
cember 2015 (even if containing data older than 1990).
Papers were excluded if at least one of the following cri-
teria were met: (i) studies did not concern T. saginata
and/or T. solium; (ii) studies did not report data from
within the specified area; (iii) studies published before
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1990 or after 1st December 2015; (iv) studies reported
results outside the scope of the study questions (includ-
ing general reviews on the topic). Papers were initially
screened for eligibility primarily based on title and
abstract, and, if necessary, the full paper was assessed. If
the full text was not available, relevant data provided in
the abstract were included. From each eligible docu-
ment, data were collected in predefined tables.
Local sources
We distributed country sheets (Additional file 2) to
members of the European Network on Taeniosis/Cysti-
cercosis (CYSTINET, COST Action TD1302) and other
experts, requesting them to list relevant national
journals, epidemiological bulletins, MSc/PhD disserta-
tion databases, national institutes, and registries, and to
translate relevant search terms. Due to ethical con-
straints, unpublished hospital or laboratory data were
requested at an aggregated level. In addition, we
searched for relevant records in meeting proceedings of
CYSTINET and the European Network for Foodborne
Parasites (Euro-FBP, COST Action FA1408). Finally, we
explored the references listed in recent topic-specific
reviews [12–14, 16] to identify any additional eligible
documents. We applied the same inclusion and exclu-
sion criteria and followed the same data collection
approach for all eligible sources. Personal communica-
tions received after 1st of December 2015 were allowed
to be included when describing data from within the
study period.
Data collection and analyses
Three independent reviewers (VD, MLG, CT) performed
the data collection. For data analysis, cases reported as
case reports providing information on individual charac-
teristics of the patient were defined as individual cases.
Cases provided at aggregated level with no individual in-
formation were defined as aggregated cases. Predefined
tables summarising individual cases included year of
diagnosis, age, gender, country of origin or nationality,
and reported risk factors, and reference (i.e. author and
publication year). Tables summarising aggregated cases
or prevalence included country, level of data collection
(e.g. national/regional), timeframe, number of cases (or
prevalence), Taenia species, risk factors (e.g. immigra-
tion/travel history) if available, and reference.
For description of risk factors, we applied the follow-
ing definitions: (i) Endemic region: Asia, Africa, South
and Central America (including Caribbean islands), and
eastern European countries; (ii) Immigrant: any person
born in or native from an endemic region, or reported
to have moved from an endemic region; (iii) Travelled/
stayed in endemic region: having travelled, stayed, or
resided in an endemic region reported in their
epidemiological history; (iv) No history of travels to en-
demic areas or immigration (autochthonous): informa-
tion on risk factors provided, but no history of travel/
immigration (outside western Europe) is reported.
In those cases where the existence of duplicates was
probable (e.g. cases included in two retrospective studies
on the same area/hospital, covering overlapping time pe-
riods, cases diagnosed in the same hospital in the same
timeframe but reported in different sources, etc.) cases
were only presented once. Descriptive analyses and graph-
ics were performed in Excel and the R software environ-
ment for statistical computing (R Core Team, 2016).
Results
Search results
The steps followed in the search strategy are presented
in Fig. 1. A total of 442 relevant references were identi-
fied and included in the review: 208 were retrieved
through online international databases (Additional file 3:
Table S2) and 234 were made available through local
sources (Additional file 4: Table S3).
The countries for which we identified relevant data or
cases of T. saginata or T. solium in humans or animals
are shown in Fig. 2. Data were retrieved from peer-
reviewed papers, governmental and scientific reports (e.g.
EFSA reports), epidemiological bulletins, dissertations,
conference abstracts, and from sources providing unpub-
lished data (e.g. registries and personal communications).
Taeniosis
We identified 86 sources providing unique information
for twelve countries: 21 records reporting 22 individual
cases and 65 providing information on aggregated cases
or prevalence. For Finland, the only information found
indicated that a handful of taeniosis cases are diagnosed
in HUSLAB yearly (T. solium being less common than
T. saginata) [20, 21]. No reports of taeniosis could be
found for Iceland, Ireland, Luxembourg, Norway,
Switzerland and Sweden.
Taeniosis case reports
In total, 22 individual cases were reported in seven
countries (Additional file 5: Table S4). Almost all were
reported as T. saginata (11 cases) or Taenia spp. (8
cases, one of them suspected to be T. saginata) (Fig. 3).
Two case reports of T. solium were found, one in Spain
(in a 19 year-old Spanish woman who had consumed
raw pork) and one in Italy (a post-mortem diagnosis in a
26-year old farmer in 1985). A T. solium case was sus-
pected in Corsica (France) in a 55 year-old woman who
had consumed a Corsican traditional dish made with un-
cooked pig intestine [22] although Galán-Puchades &
Fuentes [23] later suggested that Taenia asiatica could
have been the causative agent. None of the T. solium
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Fig. 1 Flow diagram of the search strategy steps
Fig. 2 Summary of identified data on human taeniosis and cysticercosis in western Europe (1990–2015). a Taeniosis. b Human cysticercosis. c
Porcine cysticercosis. d Bovine cysticercosis
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case reports provided details on how the species identifi-
cation was achieved.
In half of the cases, consumption of raw meat was
mentioned as a risk factor. It was not mentioned
whether the taeniosis cases could be autochthonous or
imported except for one patient who had recently
returned from a prolonged stay in Ivory Coast.
Aggregated taeniosis cases
Aggregated taeniosis cases were obtained from authorities’
reports, epidemiological bulletins, or national registries
(Additional file 5: Table S5) and from hospitals/laboratories
and epidemiological studies (Additional file 5: Table S6).
Data from authorities’ reports, epidemiological bulletins
or national registries were available for six countries cov-
ering different years. The number of cases reported per
year by each country was variable, with the UK and Spain
reporting the highest number of annual cases (Fig. 4).
Most cases were reported as Taenia spp. or T. saginata;
however, eight T. solium cases in Spain (reported in
different years between 2001 and 2008), eight in Portugal
(reported in different years between 2000 and 2011), five
in Slovenia (detected in different years between 1997 and
2011), and two in the UK (one case reported in 2002 and
another in 2003) were identified. According to Hill et al.
[24] around 98% of the cases recorded by the Health
Protection Agency in the UK in the last years were T. sagi-
nata. For most cases, no information was available in
relation to nationality, risk factors, or sources of infection.
Of all aggregated taeniosis cases reported in the UK, one
case reported having eaten raw beef and 46 cases were
connected with overseas travels. The total number of
cases per Taenia species and country is shown in the
Additional file 5: Table S5.
Aggregated taeniosis cases identified from labora-
tory/hospital data and epidemiological studies (e.g.
retrospective studies in hospitals) were identified for
seven countries (Fig. 5). Further details are presented
in the Additional file 5: Table S6.
Taeniosis prevalence data
Prevalence data were reported in regional epidemio-
logical studies conducted at hospital or laboratory level.
These studies were conducted in five countries at
different time periods and reported T. saginata or
Taenia spp. prevalences ranging between 0.05 and 0.27%
(Additional file 5: Table S7).
Based on anthelmintic drugs sales, several authors
have estimated the number of taeniosis cases or preva-
lence in a given region or country (Additional file 5:
Table S8). The estimated number of Taenia cases occur-
ring annually in Belgium and France was 11,350 and
64,495, respectively [25, 26]. Estimated prevalences
range from 0.02 to 0.67%, with the highest being
reported in Germany (0.33–0.67%) and Belgium (0.35–
0.46%) and the lowest in Denmark (0.02%) and Italy
(0.02–0.04%). In France, based on the quantification of
taeniid egg contents in sludge, Barbier et al. [27]
deducted that T. saginata taeniosis prevalence in the
Caen urban area ranged from 1.5 to 2.7% (1987–1989).
Human cysticercosis
We identified 243 relevant sources providing unique
information on human cysticercosis in all 18 countries.
Human cysticercosis case reports
A total of 275 individual cysticercosis cases were re-
ported in 17 countries (Fig. 6). No case reports were
identified for Iceland. Spain (72 cases) and France (54
cases) recorded the highest number of cases. The
average number of cases published per year was 10.6
with 2014 being the year with the highest number (25)
Fig. 3 Number of identified taeniosis cases in case reports in western Europe (1990–2015)
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and 1997 the year with the lowest number (1) reported,
respectively, among all 17 countries. The age of patients
ranged from 2 to 94 years; 129 were female and 127
male (gender unknown in 19 cases).
Information on risk factors was reported in most cases
(Additional file 5: Table S9). In 82% of cases the infec-
tion was probably acquired outside western Europe (61%
due to immigration and 21% due to travels or stays in
endemic regions). Among infected immigrants, the high-
est number of cases had emigrated from Latin America
(77), followed by Asia (39) and Africa (35), whereas 15
cases originated from eastern Europe (e.g. Albania,
Bosnia and Herzegovina, former Yugoslavia). For 5% of
cases, the infection appeared to be acquired autochtho-
nously (no travel/immigration history reported) (Table 1,
Fig. 6). For the remaining cases (13%), there was no
information on nationality or risk factors that could be
linked with the infection.
Aggregated human cysticercosis cases
Aggregated human cysticercosis cases were obtained
from authorities’ reports or registries (Additional file 5:
Table S10) and from hospital/laboratories or epidemio-
logical studies (Additional file 5: Table S11).
Data from authorities’ reports and registries were
available for six countries over different periods. The
highest number of cases was reported in Spain, with
1702 hospitalised cases with diagnosis of cysticercosis at
hospital discharge between 1997 and 2014 (range of 45–
169 hospitalisations per year), following ICD-coding
Fig. 4 Number of aggregated taeniosis cases/year reported in authorities’ reports, epidemiological bulletins and national registries in western
Europe (1990–2015). Data from Portugal do not include the autonomous regions of Madeira and Azores
Fig. 5 Number of aggregated taeniosis cases reported at hospital/laboratory level in western Europe (1990–2015). Data for Portugal correspond
to the Autonomous Region of Madeira
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systems [28]; Portugal with 1120 hospitalised cysticercosis
cases between 1993 and 2004 and 357 NCC hospitalised
cases between 2006 and 2013 (mean of 45 cases per year)
following ICD-coding systems [29, 30]; and Italy with 540
hospitalisations for cysticercosis between 2001 and 2010
(range of 40–53 per year) based on ICD-coding systems
[31]. In Denmark, the national inpatient diagnosis register
recorded 32 cases during 2012–2014 and in the
Netherlands there were 24 hospitalisations with cysticer-
cosis as primary diagnosis (following ICD codes) during
1986–1990. In Iceland, based on governmental reports
there were no cases notified in 2013–2014 [32].
Cases based on laboratory/hospital data or epidemio-
logical studies were retrieved for 13 countries. The high-
est numbers of cysticercosis cases were diagnosed in
Portugal (476) and Spain (282), followed by a lower
number in the Netherlands (147), France (135) and Italy
(90) (Fig. 7). Of these cases, 38 [diagnosed in France
(18), Italy (17), Spain (2) and Portugal (1)] had most
likely acquired the infection in western Europe based on
the travel/immigration history reported. The 18 cases
diagnosed in France were reported to have acquired the
infection mainly in the Iberian Peninsula in 1978–1988.
Further details are shown in Additional file 5: Table S11.
Porcine cysticercosis
We identified 39 relevant references providing unique
information on 14 countries: 25 provided cases and 14
provided prevalence data. No information could be
obtained for France, Iceland, Norway and Switzerland
(Additional file 5: Table S12).
Based on the available information, no cases of porcine
cysticercosis were identified during meat inspection at
slaughter in Belgium, Denmark, Finland, Ireland, Italy,
Luxembourg, the Netherlands, Sweden and the UK.
According to public authorities, T. solium in pigs has
Fig. 6 Number of identified human cysticercosis cases in case reports in western Europe (1990–2015)
Table 1 Suspected autochthonous human cysticercosis cases from case reports
Country No. of cases Background Age (yrs)
France 4 1 case: had never left Europe
1 case: had never left metropolitan France
1 case: no history of travel to endemic areas
1 case: had never left France
44–69
Germany 3 3 cases: no history of travel to foreign countries 6–69
UK 2 1 case: no history of travelling outside Europe
1 case: lack of travel to endemic areas
3–21
Portugal 2 1 case: without relevant personal background
1 case: no history of travelling abroad
57–71
Italy 1 1 case: had never visited endemic areas for cysticercosis 61
Luxembourg (infection could have been acquired in Spain) 1 1 case: born in Spain, moved to Luxembourg 8 years prior
diagnosis (annual visits to Spain)
20
Spain 1 1 case: without background of interest except for that
he was a pig breeder
70
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not been reported for many years in the UK [33]. In
Denmark, the last report of cysticerci in pork dated back
to 1894 [34] and in Italy, according to Tamburrini et al.
[35], porcine cysticercosis cases were only occasionally
observed (e.g. in Basilicata) in the past.
Porcine cysticercosis was reported during meat inspec-
tion at slaughter in Austria, Germany, Portugal, Slovenia
and Spain. Important to note, reports from Germany did
not differentiate between cases of Taenia hydatigena and
T. solium cysticercosis and Spain and Slovenia reported
porcine cysticercosis with no further information on the
causative species. Therefore, it is not possible to assess
whether these cases were of public health importance.
Slovenia notified only one case of porcine cysticercosis in
2007 (2007–2014), but it was not confirmed by any la-
boratory diagnostic method [36]. The reported prevalence
in Germany ranged from 0 to 0.0023% (2009–2012). In
Spain, the prevalence ranged from 0 to 0.20% in domestic
pigs (1999–2014); 0.16 to 0.43% in home-slaughtered pigs
(2011–2013), and 0 to 0.19% in wild boar (2009–2013).
In Extremadura (Spain), García Vallejo [37] analysed
samples of 689 Iberian pigs raised on extensive breeding
farms and could not identify any infected with T. solium
cysticerci.
Austria was the only country where the veterinary au-
thority had been annually (between 1998 and 2002)
reporting cases of T. solium [reported as “Cysticercus cel-
lulosae”: 10–40 cases/year (1999–2002); 0 cases in 1998]
[38–42]. Most of these cases were described as light infec-
tions (65 light and 23 heavy infections during 1999–2002).
In Portugal, two confirmed cases of generalised cysticer-
cosis due to T. solium were detected in 2004. One case
was a pig bought and raised for home consumption on a
farm located near Coimbra (Unpublished data, Correia da
Costa, 2016). The second case, a pig of the Bisaro breed
(traditionally raised outdoors), was detected and
confirmed at an abattoir in Vinhais (northern Portugal)
[43, 44]. More recently, and according to official data from
2008 to 2015, no cases of T. solium cysticercosis were
detected in Portugal (unpublished data, DGAV, 2016).
Bovine cysticercosis
In our review we identified 85 sources providing unique
information (prevalence or number of cases) from all
(18) countries. Prevalence data or number of cases were
mainly based on routine meat inspection (Regulation
(EC) No 854/2004) [45]. Prevalence data of bovine cysti-
cercosis was identified in fifteen out of the eighteen
countries (Figs. 8, 9). For few countries and specific
years, we retrieved the number of positive cases detected
per year (prevalence data was not available) (Additional
file 5: Table S13). Prevalence data based on more sensi-
tive methods than routine meat inspection (i.e. serology
or a more detailed meat inspection) [46, 47] were only
available for six countries (Additional file 5: Table S14).
In Iceland it has been never detected. However, it should
be noted that incisions in the heart and masseter
muscles are not routinely performed as part of meat
inspection in Iceland [48].
The majority of bovine cysticercosis cases identified
were detected after 1990. Figures 8 and 9 show the
reported prevalence detected at slaughter before 1990
and after 1990, respectively. Prevalence reported before
1990 ranged from 0.03% (Belgium in 1969–1989 and
Norway in 1989) to 6.80% (Former German Democratic
Republic in 1974–1989). After 1990, the prevalence
Fig. 7 Number of aggregated human cysticercosis cases reported at hospital/laboratory level in western Europe (1990–2015)
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ranged from 0% (some regions of Spain in 2009–2014,
one abattoir in Belgium in 2003, the UK in 2006 and
mainland Portugal during 2008–2015) up to 7.82%
(Madeira, Portugal, in 2010). After 1990, 95% of the
prevalence data reported were below 4.87% and 50%
were below 0.07%. The highest prevalence was reported
in Madeira (7.82%). Although no positive cases were
found in the Portuguese Autonomous region of Azores,
at least part of the cases detected in Madeira seemed to
have acquired the infection in Azores [49].
For Ireland and Norway, only one prevalence record
before 1990 was available: 0.62% in Ireland (1977–1980)
[50] and 0.03% in Norway (1989) [51]. However, individual
cases were reported in Norway after this date [52, 53]. For
Finland, no prevalence data could be retrieved, but 2 cases
were reported: one in 1996 and one in 2002 (Additional
file 5: Table S13).
In some reports on bovine cysticercosis, information on
the degree of infection was available. The percentage of
heavily infected cases ranged from 0.59 to 6.06% in Austria
(1998–2003), 0.49–1.61% in Belgium (2002–2013), 5.30–
6.47% in Germany (2009–2012) and 6.29–12.68% in
Madeira (2007–2013).
Prevalence data based on more sensitive methods (i.e.
serology, detailed meat inspection or modelling) ranged
from 0.54 to 38.4% (Additional file 5: Table S14). Data on
the occurrence of bovine cysticercosis according to the age
of the animal was available for four countries: the preva-
lence in calves and adult cattle ranged between 0 and 0.55%
and 0.03–1.68%, respectively (Additional file 5: Table S15).
Discussion
The aim of the current study was to collect epidemio-
logical data on T. saginata and T. solium in human and
animal hosts in western Europe. Human taeniosis cases
were identified in two thirds of the countries included in
Fig. 8 Prevalence of bovine cysticercosis based on routine meat
inspection detected in western Europe before 1990. Prevalence
estimates are from individual studies, and not the estimated
prevalence for the entire country. Abbreviations: BE, Belgium; DE,
Germany; DK, Denmark; IE, Ireland; IT, Italy; NO, Norway; SI, Slovenia;
UK, United Kingdom
Fig. 9 Prevalence of bovine cysticercosis based on routine meat inspection detected in western Europe after 1990. Prevalence estimates are from
separate local studies. Data for Portugal correspond to the Autonomous Region of Madeira. Prevalences higher than 6.5%, which correspond to
prevalences up to 7.82% detected in Madeira (2010), are not presented in the figure. Abbreviations: BE, Belgium; CH, Switzerland; DE, Germany; DK,
Denmark; ES, Spain; FR, France; IT, Italy; LU, Luxembourg; NL, The Netherlands; PT, Portugal; SE, Sweden; SI, Slovenia; UK, United Kingdom
Laranjo-González et al. Parasites & Vectors  (2017) 10:349 Page 9 of 14
the search. Overall, the number of sources providing
data was limited and the annual number of taeniosis
cases found equally low for most countries, except for
the UK and Spain. However, estimates based on
anthelmintic sales (e.g. niclosamide) [25, 26, 54–58] or
detection of Taeniidae eggs in sewage [27], although
approximate, suggest that the true number of taeniosis
cases is far from negligible. Indeed, we assume a serious
underestimation, due to the fact that taeniosis is not a
notifiable disease, the perceived low health impact, and a
possible low awareness among medical doctors about
the potential presence of T. solium carriers [14, 59] with
a high public health impact. We further hypothesize
that, as a consequence, the diagnosis is often based ex-
clusively on patient’s reporting shedding of proglottids
without any laboratory confirmation. Our results also
highlight that species differentiation is rarely performed
for taeniosis cases, reflected by the high proportion of
cases reporting “Taenia spp.” as the causative agent.
Next to the reasons discussed previously related to the
perceived low health impact of the disease, diagnostic
limitations might play a role for those cases for whom
stool examination was performed. Indeed, Taenia spp.
eggs are morphologically identical, and while differen-
tiation can be made based on the number of uterus
branches of expelled proglottids, such material is not
always available. Furthermore, stool examination by
molecular methods is not often performed [60]. Over-
all, given the lack of species differentiation in addition
to the overall assumed underestimation of cases, it is
difficult to estimate the true number of taeniosis
cases caused by either T. saginata or T. solium in
western Europe.
Taenia saginata is responsible for continuous economic
losses for the meat industry, due to the condemnation or
freezing of affected carcasses [3, 61] as prescribed in the
European Regulation (EC) No 854/2004 [45]. Carriers of
T. saginata contribute to these financial losses by sustain-
ing the parasite’s life-cycle. In our search, T. saginata
taeniosis cases were identified in Austria, Belgium,
Denmark, Finland, France, Germany, Italy, Netherlands,
Portugal, Spain, Slovenia and the UK. The presence of
bovine cysticercosis was reported in nearly all countries
included in the search, at different prevalence levels. As
most of the data on T. saginata in cattle retrieved were
based on meat inspection, a hugely insensitive detection
method (reported sensitivity of 15.6%; [62]), we assume an
underestimation of cases [46, 63]. A few false positive cases
could also be present, as other causes of macroscopic le-
sions (e.g. abscesses, Sarcocystis cysts) could be confused
with calcified cysticerci by meat inspection [59, 64]. Thus,
more sensitive diagnostic tools should be implemented and
species differentiation should be done in case of doubt.
Furthermore, data reporting should be improved. Austria,
for example, used to report findings on T. saginata at
slaughter (1998–2003) but at present any (unspecified)
cysts found in cattle are reported under the term “echino-
coccosis” [65–71]. For some countries (e.g. Norway,
Finland) only sporadic cases of bovine cysticercosis were
reported, which could be due to the lack of good reporting
systems, as well as to the low prevalence or even absence
of the parasite, due to the lack of favourable conditions for
its transmission in these areas (e.g. lack of raw meat con-
sumption, or lack of environmental factors such as use of
sewage sludge on pastures).
Taenia solium taeniosis cases were reported in
Denmark, France, Italy, Portugal, Spain, Slovenia and the
UK, but the diagnostic methods used for identifying the
Taenia species were often not clearly described [72]. On
the individual level, identification of T. solium taeniosis
cases is extremely relevant as one tapeworm carrier, if not
treated, can pose a significant health risk to both them-
selves and to people in contact, as ingestion of infective
eggs can lead to cysticercosis [11]. From the available data,
it was not clear whether any of the reported T. solium
taeniosis cases could have been acquired within western
Europe through consumption of infected pork. However,
as we can assume that most T. solium taeniosis cases were
imported, prevalence studies in risk groups, such as travel-
lers and immigrants, would be recommended. Further-
more, the epidemiological situation of T. solium in pigs
was found to be unclear for many countries in western
Europe: only five countries reported porcine cysticercosis
cases and they usually did not report the causative species
(i.e. cysticerci could also be T. hydatigena). Moreover,
current reporting systems are often not consistent. For
instance, in Austria similar to the cattle data previously
discussed, nowadays only unspecified cysts are being re-
ported for pigs [65–71]. Given the public health impact of
T. solium, and because cysts of different Taenia spp. may
not be distinguishable in the early stages [9], molecular
confirmation should be performed in suspected porcine
cysticercosis cases and the reporting should be made at
species level, as recommended by EFSA [73]. Only
Portugal reported two cases of T. solium in pigs, con-
firmed by molecular methods, one pig being raised out-
doors and another bought for home consumption)
(Correia da Costa, pers. com., 2016) [43, 44] supporting
the hypothesis that in some rural areas in western Europe,
favourable conditions might still exist for T. solium trans-
mission (e.g. outdoor pig farming and contact with faeces
from tapeworm carriers). In theory, increasing immi-
gration and travels, combined with increasing outdoor
pig farming (e.g. organic pig farming) may contribute
to a future re-establishment of T. solium local trans-
mission in many areas [9, 10] and we may expect
there to be a rise in porcine cysticercosis cases in
western Europe in the near future [9, 10].
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Humans can act as dead-end host for T. solium, upon
ingestion of eggs shed by a T. solium tapeworm carrier.
The burden of human cysticercosis, especially in cases
of NCC, is massive and it is believed to be the food-
borne parasitic infection incurring the largest number of
disability adjusted life years globally [74]. We found
human cysticercosis cases in all western European
countries included in the search, except Iceland. In some
countries (e.g. Belgium, Finland, Ireland, Luxembourg,
Norway, Sweden and Switzerland) included in our
search, a cysticercosis case seemed to be a rare finding,
whereas in countries like France, and especially the most
southern countries in our search (Spain and Portugal),
cases were more frequently observed. Based on the
available epidemiological information, it was apparent
that most human cysticercosis cases diagnosed in
western Europe were linked to immigration or travel to
endemic countries. The absolute number of cases in im-
migrants appear to have increased in recent years, with a
large number of cases originating from Latin America
and the Caribbean, possibly due to a rapid increase in
immigration from this area towards Europe, mostly to
the southern European countries, around the transition
from the 20th to the twenty-first century [75]. Immigra-
tion from Africa has increased throughout the last
decade and is expected to increase further [76]; we
might therefore observe a rise in imported cases from
African countries in the coming years. In addition, some
cysticercosis cases originated from eastern Europe where
favourable conditions for local T. solium transmission also
seem to exist [8, 10]. Increased mobility, possibly associ-
ated with the introduction of the Schengen zone [9], could
thus also result in a rise of imported cases from that re-
gion. In our review, we identified few human cysticercosis
cases suspected to be autochthonously acquired. However,
the exact place and time of infection and whether local
transmission from an imported T. solium tapeworm car-
rier might have occurred could not be determined from
the available data. Overall, although false positive cases of
cysticercosis are possible in serological tests due to cross-
reactions [77], the number of NCC cases identified in our
search is probably lower than the actual number, as some
NCC cases might not exhibit symptoms [78], the sero-
logical reference test exhibits a low sensitivity in case of
single viable or calcified lesions [79], and clinicians in
these non-endemic areas lack experience with the disease
and therefore might not recognize it [59].
Conclusions
The fact that both taeniosis and human cysticercosis are
mainly non-notifiable diseases implies the absence of sys-
tematic data collection and reporting, leading to fragmen-
ted data. Overall, due to the economic impact of T.
saginata and the potential impact on public health of T.
solium, the improved detection and reporting of human
taeniosis cases is extremely relevant for control and surveil-
lance purposes. By maintaining the parasite life-cycle, T.
saginata tapeworm carriers contribute to continuous eco-
nomic losses in the meat sector. Furthermore, despite the
low health impact, acquiring T. saginata taeniosis should
not be acceptable from a food safety perspective. The exist-
ence of T. solium tapeworm carriers, combined with the
presence of suspected autochthonous cases of human cysti-
cercosis as well as the lack of confirmation of porcine cysti-
cercosis cases in most countries, deserves further attention.
We might see a rise in imported human cysticercosis in the
near future due to increased migration from endemic coun-
tries. Species identification of taeniosis cases should be
encouraged and epidemiological investigations carried out
to detect whether local transmission of T. solium may
occur. Furthermore, suspected cases of T. solium in pigs
should be confirmed by molecular methods. Both taeniosis
and human cysticercosis should be notifiable and surveil-
lance and reporting in animals should be improved.
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